Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study

OBJECTIVE: This study investigates the effectiveness and tolerability of switching to a darunavir/cobicistat (DRV/c)-based antiretroviral regimen from a ritonavir-boosted protease inhibitor (PI/r)-based regimen in virologically suppressed HIV-positive patients. DRV trough values were also investigat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Acquir Immune Defic Syndr
Hoofdauteurs: Gori, Andrea, Antinori, Andrea, Vergori, Alessandra, Cossu, Maria Vittoria, Menzaghi, Barbara, Sterrantino, Gaetana, Rusconi, Stefano, Cattelan, Anna Maria, Castelli, Francesco, Gianotti, Nicola, Orofino, Giancarlo, Ripamonti, Diego, Savinelli, Stefano, Manzillo, Elio, Santantonio, Teresa Antonia, Celesia, Benedetto Maurizio, Cauda, Roberto, Maserati, Renato, d'Arminio Monforte, Antonella, Stingone, Christof, Bonora, Stefano, Uglietti, Alessia, Termini, Roberta, Rucci, Francesco, Mancusi, Daniela
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Onderwerpen:
Clinical Science
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289135/
https://ncbi.nlm.nih.gov/pubmed/32101882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002331
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items